South San Francisco, CA -- September 13, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United...
Vous n'êtes pas connecté
ImmPACT Bio USA Inc. (ImmPACT Bio), a clinical─stage biopharmaceutical company, announced the United States Food and Drug Administration (FDA) has cleared an investigational new drug
South San Francisco, CA -- September 13, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United...
KalVista announces FDA acceptance of New Drug Application for sebetralstat for oral on-demand treatment of hereditary angioedema KalVista...
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S....
Competitive: Worldwide Clinical Trials - USA: Who we are Worldwide Clinical Trials (Worldwide), a leading global contract research organization...
Competitive: Worldwide Clinical Trials - USA: Who we are Worldwide Clinical Trials (Worldwide), a leading global contract research organization...
Learn why the FDA has mandated boxed warnings for CAR T-cell therapies, highlighting the risks of secondary malignancies.
Drug company Indies Pharma Jamaica Limited is looking to double next year’s revenues, following approval of its abbreviated new drug application,...
Highlights: Secondary Primary Malignancy rates did not significantly differ among various CAR T-cell therapies or c
Highlights: Secondary Primary Malignancy rates did not significantly differ among various CAR T-cell therapies or c
Stealth BioTherapeutics Inc., a clinical─stage biotechnology company focused on the discovery, development and commercialization of novel therapies...